New partnership
Medis and PAION Have Signed Commercialization Agreement for Three Innovative Hospital Therapies
Ähnliche Neuigkeiten
BIAL and Medis entered into a partnership for innovative medicines for the central nervous system
BIAL and Medis announce that they have entered into an exclusive partner-ship on two BIAL's proprietary medicines eslicarbazepine acetate and opicapone.
Lesen Sie mehr
A new partnership with Neurim Pharmaceuticals Ltd.
Our exclusive distribution agreement for the commercialization of Slenyto® represents an important milestone for both companies.
Lesen Sie mehr